In developing Medtronic's deep brain stimulation systems, how do we weigh the benefits of increased precision against the potential for higher surgical complexity?

Introduction

In developing Medtronic's deep brain stimulation systems, we face a critical trade-off between increased precision and potential higher surgical complexity. This scenario involves balancing the benefits of more targeted treatment against the risks and challenges associated with more intricate surgical procedures. I'll analyze this trade-off through the lens of product strategy, user impact, technical feasibility, and business implications.

Step 1

Clarifying Questions (3 minutes)

• Based on the current market landscape, I'm thinking precision might be a key differentiator. Could you provide more context on how our competitors are positioning their deep brain stimulation systems?

Why it matters: Helps understand our unique value proposition Expected answer: Competitors focus on ease of use, we have an opportunity in precision Impact on approach: Would emphasize precision in product development and marketing

• Considering patient outcomes, I'm assuming increased precision could lead to better efficacy. Do we have any preliminary data on how increased precision correlates with patient outcomes in deep brain stimulation?

Why it matters: Validates the core assumption behind pursuing increased precision Expected answer: Early studies show promising results, but more data needed Impact on approach: Would influence the balance between pursuing precision and managing complexity

• From a regulatory standpoint, I'm thinking increased surgical complexity might require additional approvals. What's our current understanding of the regulatory landscape for more complex deep brain stimulation procedures?

Why it matters: Affects timeline and resource allocation for product development Expected answer: Additional clinical trials and approvals likely needed Impact on approach: Would factor into decision-making process and development timeline

• Regarding our surgical partners, I'm curious about their capacity to adapt to more complex procedures. What's the current feedback from neurosurgeons on increasing the complexity of deep brain stimulation systems?

Why it matters: Assesses feasibility and potential adoption barriers Expected answer: Mixed feedback, concerns about learning curve and operating time Impact on approach: Would influence training programs and potential phased rollout

• Looking at our R&D capabilities, I'm wondering about our team's expertise in balancing precision and complexity. How confident are we in our ability to innovate in this space without significantly increasing surgical risks?

Why it matters: Determines internal capacity to execute on the precision-complexity trade-off Expected answer: Strong theoretical knowledge, but practical implementation challenges remain Impact on approach: Would inform resource allocation and potential partnerships